Karl Naegler
Partner
Works at Sofinnova
Investor profile | Builders Republic
About
Partner at Sofinnova, Karl Naegler invests in pre-seed, seed, Series A, Series B, and growth with check sizes ranging from €1 to €60 million, focusing on health and life sciences, agrifood, climate, and cleantech. He has been a Partner in the Capital Strategy since September 2024 and has 20 years of investment experience. His track record includes Actithera, Seamless Therapeutics, Breath Therapeutics, Covagen, and Prosonix. He was Managing Partner at Wellington Partners Life Sciences, then Partner at Gimv, Ventech, and Atlas Venture. Education: PhD in molecular neurobiology (Max-Delbrück-Center).
Profile
- Role
- Partner
- Fund
- Sofinnova